|
 |
|
|
|||
|
 |
|
Oct. 17, 2011 Source: Ceva Animal Health news release Ceva Santé Animale is pleased to announce the appointment of Daryl Pint to Chief Executive Officer of its Ceva Biomune Campus in Lenexa, Kansas. Pint ascends to the role from his position as vice president of industrial operations and reports to Thierry Le Flohic, Global Biotech Campus Management and Industrial Operations Director for the Biology Business Unit. He is responsible for management of the Campus, including all departments and functions dedicated to biologics: research and development, regulatory affairs and compliance, production, and all support related functions. Pint will also represent Ceva on the KC Animal Health Corridor advisory board. Pint joined the company in the fall of 2010, quickly assuming responsibility for the completion of a new manufacturing plant dedicated to recombinant vaccines. He is a biotechnology industry veteran with 27 years of diverse, hands-on experience in all phases of biotech operations management. Prior to Ceva, Pint was the senior manager of technical operations for Novartis. For nearly 20 years, he helped Fort Dodge Animal Health increase efficiency, manage budgets and supply, and handle daily operations for a variety of business units and plants. "Daryl's primary goal is to reinforce Campus leadership within our organization and to continue to invest in our people. His endorsement and implementation of the 3 Ceva Values in the past months - Innovation, Entrepreneurship and Solidarity to better serve our Customers - are the living proof of his capacity to handle this broad management role," said Dr. Arnaud Bourgeois, Vice President of Biology for Ceva Sante Animale. Dr. Bourgeois continues to oversee the global biology unit for Ceva Sante Animale. Having directed and grown American and global biology businesses for five years, he returned to headquarters in France in September to focus on generating further growth through Ceva's highly strategic biological business. Ceva's mission, "Together, beyond animal health" references the undeniable role that animal health plays in shaping human health. Ceva's Biomune campus is particularly focused on providing resources that will help our partners feed a growing population and prevent the expansion of zoonosis, or diseases transmitted from animals to humans. About Ceva: In North America, Ceva's key poultry products include CEVAC Transmune IBD, Vectormune FP and Vectormune HVT. Key companion animal products include the Vectra line of parasiticides, D.A.P. and Feliway pheromone behavior aids and Senilife neuroprotection for aging pets. Ceva's North America Zone headquarters are located in Lenexa, Kansas. Visit www.ceva.us. Ceva is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry. Its headquarters is in Libourne, France. Visit www.ceva.com. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
